Aridis Pharmaceuticals, Inc.

ARDS · OTC
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Activities
Net Income-$30-$42-$22-$30
Dep. & Amort.$0$0$0$0
Deferred Tax$0-$1$0$0
Stock-Based Comp.$1$2$2$2
Change in WC-$1$11-$1$18
Other Non-Cash$1$7$0$1
Operating Cash Flow-$29-$23-$20-$8
Investing Activities
PP&E Inv.-$0-$1-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0-$1-$0-$0
Financing Activities
Debt Repay.$3$5$1$0
Stock Issued$13$30$8$5
Stock Repurch.$0$0$0$0
Dividends Paid$0-$4$0$0
Other Fin. Act.-$1$4$0$0
Financing Cash Flow$15$35$9$5
Forex Effect$0$0$0$0
Net Chg. in Cash-$14$11-$12-$3
Supplemental Information
Beg. Cash$20$9$21$24
End Cash$6$20$9$21
Free Cash Flow-$29-$23-$21-$8